Synopsis
Synopsis
0
CEP/COS
0
VMF
0
FDF
0
South Africa
DRUG PRODUCT COMPOSITIONS0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2-((6-((3r)-3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)methyl) Benzonitrile
2. Alogliptin
3. Nesina
4. Syr 322
5. Syr-322
6. Syr322
1. 850649-62-6
2. Nesina
3. Syr 322
4. Syr-322
5. Alogliptin (benzoate)
6. (r)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)methyl)benzonitrile Benzoate
7. 850649-62-6 (benzoate)
8. Alogliptin (as Benzoate)
9. Een99869sc
10. Chebi:72324
11. 2-((6-((3r)-3-amino-1-piperidinyl)-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)- Pyrimidinyl)methyl)benzonitrile Monobenzoate
12. 2-[[6-[(3r)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxopyrimidin-1-yl]methyl]benzonitrile;benzoic Acid
13. 6-((3r)-3-aminopiperidin-1-yl)-1-(2-cyanobenzyl)-3-methylpyrimidin-2,4(1h,3h)-dione Monobenzoate
14. Benzonitrile, 2-((6-((3r)-3-amino-1-piperidinyl)-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl)methyl)-, Monobenzoate
15. Alogliptin, Benzoate
16. Alogliptin Benzoate [usan]
17. Unii-een99869sc
18. Mfcd09833195
19. Alogliptin Benzoate [usan:jan]
20. Vipidia (tn)
21. Nesina (tn)
22. Alogliptin Monobenzoate
23. Alogliptin(syr-322)
24. Schembl476231
25. Chembl227529
26. Alogliptin Benzoate [mi]
27. Alogliptin Benzoate (jan/usan)
28. Alogliptin Benzoate [jan]
29. Dtxsid20582095
30. Alogliptin Benzoate [vandf]
31. Alogliptin Benzoate [mart.]
32. Bcp08885
33. Hy-a0023
34. Ac-021
35. Alogliptin Benzoate [who-dd]
36. Akos015917686
37. Cs-0761
38. Alogliptin Benzoate [orange Book]
39. 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]benzonitrile Benzoate
40. As-14073
41. Oseni Component Alogliptin Benzoate
42. Kazano Component Alogliptin Benzoate
43. Alogliptin Pound Syr-322 Pound(c)benzoate
44. Alogliptin Benzoate Component Of Oseni
45. Am20090704
46. Alogliptin Benzoate Component Of Kazano
47. D06553
48. Q27888443
49. Syr 322 Benzoate; Syr-322 Benzoate; Syr322 Benzoate
50. (3r)-1-[3-(2-cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl]piperidin-3-aminium Benzoate
51. 2-((6-((3r)-3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)methyl)benzonitrile Monobenzoate
52. 2-({6-[(3r)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl}methyl)benzonitrile Benzoate
53. Benzoic Acid--2-({6-[(3r)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl}methyl)benzonitrile (1/1)
54. Benzonitrile, 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-, Benzoate (1:1)
| Molecular Weight | 461.5 g/mol |
|---|---|
| Molecular Formula | C25H27N5O4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 4 |
| Exact Mass | 461.20630436 g/mol |
| Monoisotopic Mass | 461.20630436 g/mol |
| Topological Polar Surface Area | 131 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 726 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Nesina |
| PubMed Health | Alogliptin (By mouth) |
| Drug Classes | Antidiabetic |
| Drug Label | NESINA tablets contain the active ingredient alogliptin, which is a selective, orally bioavailable inhibitor of the enzymatic activity of dipeptidyl peptidase-4 (DPP-4).Chemically, alogliptin is prepared as a benzoate salt, which is identified as 2-(... |
| Active Ingredient | Alogliptin benzoate |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | eq 12.5mg base; eq 6.25mg base; eq 25mg base |
| Market Status | Prescription |
| Company | Takeda Pharms Usa |
| 2 of 2 | |
|---|---|
| Drug Name | Nesina |
| PubMed Health | Alogliptin (By mouth) |
| Drug Classes | Antidiabetic |
| Drug Label | NESINA tablets contain the active ingredient alogliptin, which is a selective, orally bioavailable inhibitor of the enzymatic activity of dipeptidyl peptidase-4 (DPP-4).Chemically, alogliptin is prepared as a benzoate salt, which is identified as 2-(... |
| Active Ingredient | Alogliptin benzoate |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | eq 12.5mg base; eq 6.25mg base; eq 25mg base |
| Market Status | Prescription |
| Company | Takeda Pharms Usa |
Vipidia is indicated in adults aged 18 years and older with type 2 diabetes mellitus to improve glycaemic control in combination with other glucose lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycaemic control (see sections 4. 4, 4. 5 and 5. 1 for available data on different combinations).
Dipeptidyl-Peptidase IV Inhibitors
Compounds that suppress the degradation of INCRETINS by blocking the action of DIPEPTIDYL-PEPTIDASE IV. This helps to correct the defective INSULIN and GLUCAGON secretion characteristic of TYPE 2 DIABETES MELLITUS by stimulating insulin secretion and suppressing glucagon release. (See all compounds classified as Dipeptidyl-Peptidase IV Inhibitors.)
Hypoglycemic Agents
Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)
Incretins
Peptides which stimulate INSULIN release from the PANCREATIC BETA CELLS following oral nutrient ingestion, or postprandially. (See all compounds classified as Incretins.)
A10BH04
API SUPPLIERS
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Click Us!
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37908
Submission : 2022-12-30
Status : Active
Type : II
NDC Package Code : 42765-057
Start Marketing Date : 2023-01-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
Nortec Quimica is the largest API manufacturer in Latin America.
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39376
Submission : 2024-01-08
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-09-02
Pay. Date : 2016-06-13
DMF Number : 30577
Submission : 2016-07-18
Status : Active
Type : II
Registration Number : 306MF10015
Registrant's Address : H. No. &8-3-166/7/1, Erragadda, Hyderabad-500018, Telangana, INDIA.
Initial Date of Registration : 2024-01-24
Latest Date of Registration : --
Date of Issue : 2019-07-26
Valid Till : 2022-05-05
Written Confirmation Number : WC-0362
Address of the Firm : Unit-III Plot No.4 Hetero Infrastructure SEZ N.Narasapuram Village, Nakkapally mandal, Visakhapatnam Dist AP India
NDC Package Code : 69037-0024
Start Marketing Date : 2013-01-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : FarmChem Service Co., Ltd.
Registration Date : 2024-01-24
Registration Number : Number 331-11-ND(3)
Manufacturer Name : Honor Lab Limited (Unit-III)
Manufacturer Address : Plot No.4, Hetero Infrastructure SEZ Ltd., N.Narsapuram Nakkapalli Mandal, Anakapalli District, Andhra Pradesh, India
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-04-19
Pay. Date : 2016-03-17
DMF Number : 30057
Submission : 2016-02-08
Status : Active
Type : II
Date of Issue : 2022-05-27
Valid Till : 2023-11-23
Written Confirmation Number : WC-0310A3-4
Address of the Firm : Plot No.Z-103/I Dahej Sez, Phase-II Dahej, Dist Bharuch, Gujarat
NDC Package Code : 66039-924
Start Marketing Date : 2016-08-02
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-12-20
Pay. Date : 2016-09-13
DMF Number : 30913
Submission : 2016-09-30
Status : Active
Type : II
Registrant Name : Masung LS Co., Ltd.
Registration Date : 2022-05-16
Registration Number : Wed163-24-ND
Manufacturer Name : Ruyuan Hec Pharm Co., Ltd
Manufacturer Address : Xiaba Development Zone, Ruyuan County, Shaoguan City, Guangdong Province, China
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
(R)-3-Amino-piperidine dihydrochloride
CAS Number : CAS-334618-23-4
End Use API : Alogliptin Benzoate
About The Company : We are into manufacturing of bulk drug Intermediates and Active Pharmaceutical Ingredients (API). Our core competence is contract manufacturing for our clients ...
CAS Number : CAS-309956-78-3
End Use API : Alogliptin Benzoate
About The Company : We are into manufacturing of bulk drug Intermediates and Active Pharmaceutical Ingredients (API). Our core competence is contract manufacturing for our clients ...
2-(Chloromethyl)-4-methylquinazoline
CAS Number : CAS-109113-72-6
End Use API : Alogliptin Benzoate
About The Company : We are into manufacturing of bulk drug Intermediates and Active Pharmaceutical Ingredients (API). Our core competence is contract manufacturing for our clients ...
8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine
CAS Number : CAS-666816-98-4
End Use API : Alogliptin Benzoate
About The Company : We are into manufacturing of bulk drug Intermediates and Active Pharmaceutical Ingredients (API). Our core competence is contract manufacturing for our clients ...
CAS Number : 4318-56-3
End Use API : Alogliptin Benzoate
About The Company : The Bakul Group of companies headquartered in Mumbai, India are engaged in the development and manufacture of high-quality Active Pharmaceutical Ingredients (AP...
CAS Number : 4318-56-3
End Use API : Alogliptin Benzoate
About The Company : Bulat Pharmaceutical is a fast growing pharmaceutical company, founded in the year 2017, Bulat Pharmaceutical is engaged in the manufacturing and sales of high ...
(R)-3- Aminopiparidine Dihydrochloride
CAS Number : 334618-23-4
End Use API : Alogliptin Benzoate
About The Company : Bulat Pharmaceutical is a fast growing pharmaceutical company, founded in the year 2017, Bulat Pharmaceutical is engaged in the manufacturing and sales of high ...
CAS Number : 22115-41-9
End Use API : Alogliptin Benzoate
About The Company : Bulat Pharmaceutical is a fast growing pharmaceutical company, founded in the year 2017, Bulat Pharmaceutical is engaged in the manufacturing and sales of high ...
(R)-3-Piperidinamine dihydrochloride
CAS Number : 334618-23-4
End Use API : Alogliptin Benzoate
About The Company : Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technologi...
CAS Number : 4318-56-3
End Use API : Alogliptin Benzoate
About The Company : Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technologi...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
Regulatory Info :
Registration Country : Sweden
Brand Name : Vipidia
Dosage Form : FILMDRAGERAD TABLETT
Dosage Strength : 6,25 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Italy
Brand Name : Vipidia
Dosage Form : Alogliptin 6,5Mg 28 Combined Oral Use
Dosage Strength : 28 cpr riv 6.25 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Vipidia
Dosage Form : Alogliptin 12.5Mg 28 Combined Oral Use
Dosage Strength : 28 cpr riv 12.5 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Vipidia
Dosage Form : Alogliptin 25Mg 28 Combined Oral Use
Dosage Strength : 28 cpr riv 25 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
ALOGLIPTIN BENZOATE; Pioglitazone
Brand Name : Incresync
Dosage Form : Alogliptin+Pioglitazone 25Mg+30Mg 28 Combined Oral Use
Dosage Strength : 28 cpr riv 25 mg + 30 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Vipidia
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 12.5 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Vipidia
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 12.5 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Pioglitazone; ALOGLIPTIN BENZOATE
Brand Name : Incr Sync
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 12.5MG; 30MG
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Pioglitazone; ALOGLIPTIN BENZOATE
Brand Name : Incr Sync
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 25MG; 30MG
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Metformin; ALOGLIPTIN BENZOATE
Brand Name : Vipdomet
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 12.5MG; 1000MG
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
Regulatory Info : Prescription
Registration Country : Canada
ALOGLIPTIN (ALOGLIPTIN BENZOATE)
Brand Name : NESINA
Dosage Form : TABLET
Dosage Strength : 6.25MG
Packaging : 30
Approval Date :
Application Number : 2417189
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
ALOGLIPTIN (ALOGLIPTIN BENZOATE)
Brand Name : NESINA
Dosage Form : TABLET
Dosage Strength : 12.5MG
Packaging : 30
Approval Date :
Application Number : 2417197
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
ALOGLIPTIN (ALOGLIPTIN BENZOATE)
Brand Name : NESINA
Dosage Form : TABLET
Dosage Strength : 25MG
Packaging : 30
Approval Date :
Application Number : 2417200
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
ALOGLIPTIN (ALOGLIPTIN BENZOATE)
Brand Name : KAZANO
Dosage Form : TABLET
Dosage Strength : 12.5MG
Packaging : 60
Approval Date :
Application Number : 2417219
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
ALOGLIPTIN (ALOGLIPTIN BENZOATE)
Brand Name : KAZANO
Dosage Form : TABLET
Dosage Strength : 12.5MG
Packaging : 60
Approval Date :
Application Number : 2417227
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
ALOGLIPTIN (ALOGLIPTIN BENZOATE)
Brand Name : KAZANO
Dosage Form : TABLET
Dosage Strength : 12.5MG
Packaging : 60
Approval Date :
Application Number : 2417235
Regulatory Info : Prescription
Registration Country : Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Nesina
Dosage Form : tablet
Dosage Strength : 6.25 mg
Packaging : 28
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Australia
Brand Name : Nesina
Dosage Form : tablet
Dosage Strength : 25 mg
Packaging : 28
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Australia
Brand Name : Nesina
Dosage Form : tablet
Dosage Strength : 12.5 mg
Packaging : 28
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Australia
Brand Name : Nesina
Dosage Form : tablet
Dosage Strength : 12.5 mg
Packaging : 28
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Australia
Brand Name : Nesina
Dosage Form : tablet
Dosage Strength : 6.25 mg
Packaging : 28
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Australia
Brand Name : Nesina
Dosage Form : tablet
Dosage Strength : 25 mg
Packaging : 28
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - TABLET;ORAL - EQ 12.5MG BASE;1GM
USFDA APPLICATION NUMBER - 203414
DOSAGE - TABLET;ORAL - EQ 12.5MG BASE;500MG
USFDA APPLICATION NUMBER - 203414
DOSAGE - TABLET;ORAL - EQ 12.5MG BASE
USFDA APPLICATION NUMBER - 22271
DOSAGE - TABLET;ORAL - EQ 25MG BASE
USFDA APPLICATION NUMBER - 22271
DOSAGE - TABLET;ORAL - EQ 6.25MG BASE
USFDA APPLICATION NUMBER - 22271
Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Jai Radhe Sales
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ulanqab Kema New Material
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Direct Compression
Granulation
Disintegrants & Superdisintegrants
Co-Processed Excipients
Thickeners and Stabilizers
Lubricants & Glidants
Taste Masking
Chewable & Orodispersible Aids
Coating Systems & Additives
Controlled & Modified Release
Parenteral
Solubilizers
Film Formers & Plasticizers
Coloring Agents
Rheology Modifiers
API Stability Enhancers
Emulsifying Agents
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Patents & EXCLUSIVITIES
US Patents
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
Market Place
